how to recognize a good clinical trial?

Clinical trials on nutraceutical products are increasingly widespread and their promotion is becoming a vital asset for achieving market success. However, not all clinical trials are created equal. What are the factors that make a trial “good”?

Consumers are becoming more educated and proactive when deciding which nutraceutical products to buy. They are increasingly paying attention to proof of efficacy. With big pharma brands stepping into nutraceuticals, the rules are shifting, and clinical substantiation’s importance is increasing rapidly even on the finished products.

How do we distinguish good clinical trials from the rest?

Which factors determine the quality of a clinical trial?

The factors that determine a good clinical trial are:

  • statistics
  • population
  • adhering to Study Standards
  • ability to replicate the study
  • following the guidelines for sharing the results

Watch the video or continue reading to find out more.

Also important and adding to credibility:

  • The study is registered a publicly accessible database (ensures openness, allows verification and prevents selective reporting of results, and adds to transparency and accountability).
  • The results of the study are published in a peer-reviewed journal (withstands scientific scrutiny and adds to trust).

Statistics.

A good clinical trial meticulously plans its statistics in advance – from sample size to anticipated effects. This precision is crucial for obtaining results than are not only relevant but also open to a meaningful interpretation.

Principles, such as control group, double blinding, and randomization are important to establish causality, control for placebo responses and other nonspecific effects, and reduce selection bias. Moreover, when designing a clinical trial, one should also consider maintaining the product formulation, dosage, and format for solid substantiation.

Due to fast-paced lifestyle, consumers demand more convenient delivery formats for their food supplements, so they can use them on the go.

Population.

Next, consider the chosen population. Food supplements are designed for everyday use, not for treating disease symptoms. Therefore, clinical studies on nutraceutical products should focus on individuals with a moderate deficiency or problem. The higher the deficiency, the faster or more pronounced the effects (of supplementation), but these are less relevant in terms of everyday use for consumers who suffer from a moderate deficiency.

Study standards.

GCP refers to internationally recognized standards that guide how clinical studies are planned and conducted. Although mandatory for pharmaceutical clinical trials, GCP is not legally required for nutraceutical studies but is widely regarded as the gold standard for high-quality clinical research. Studies that follow GCP are designed to protect participants’ safety and rights, and to ensure that every step of the study is anticipated, traceable, and well documented and the results reliable and trustworthy.

If you want to be able to replicate a clinical study, it is imperative you thoroughly describe every step of the process.

Thorough description.

The desire is for things to be as thoroughly described as possible. To know which methods were used in the study and to have enough general data about what happened during the study so that one can replicate the study themselves.

Sharing results.

When it comes to sharing results, it is advisable to be in line with the CONSORT guidelines for reporting the results of clinical trials. In practice, this means that when you’re preparing an article, you systematically follow the checklist and present outcomes in a clean, transparent, and complete manner. Optimal transparency and minimal risk of bias are achieved when the sources of funding and independence of the research team are clearly stated.

In the end, not only the pros but also the negative aspects of the research should be highlighted.

In summary, a good clinical trial on nutraceutical products involves a blend of statistical precision, thoughtful population selection, meticulous documentation, adherence to study standards, and transparency in reporting. As the world of food supplements evolves, these criteria become the cornerstone for building trust and credibility in the eyes of both consumers and industry experts.

Current challenges and future opportunities.

Updated January 23rd 2026

  • Difficulty in or lack of translating scientific evidence into clear consumer guidance: results should besides scientifically (as intended for healthcare professionals) also be communicated to end-users in a way that is meaningful and scientifically accurate rather than purely marketing-driven.
  • Opportunity for leveraging biomarkers (genetic profiles, metabolic patterns, or microbiome characteristics) to identify subgroups of participants that are most likely to benefit: this would enable tailored interventions, would improve trial efficacy, and provide consumers with more personalized, meaningful health solutions.
  • Development of universally accepted standards for nutraceutical studies would allow their design, conduct, and results to withstand regulatory and scientific scrutiny and improve regulatory as well as consumer trust.
  • Development of agreed-upon biomarkers, validated endpoints, and measurable health outcomes for nutraceutical efficacy would allow trials to more accurately capture meaningful benefits. Nutraceutical effects are milder and more variable than those of pharmaceuticals and the established thresholds for clinical significance used in drug trials may not apply; small or subtle effects typically observed in trials of nutraceuticals do not necessarily indicate ineffectiveness, but rather reflect the populations studied (patients vs. healthy individuals/individuals with minor nutrient deficiencies).

reach out.

"*" indicates required fields

Max. file size: 30 MB.

Oops! We could not locate your form.

"*" indicates required fields

PharmaLinea © 2026